Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) EBITDA (2009 - 2013)

Updated

Kazia Therapeutics' EBITDA was -$16 million in FY2024 (year ended Dec 31, 2024), compared with -$11.92 million in FY2023.

Analysis

Kazia Therapeutics (KZIA) EBITDA (2009 - 2013) Analysis & Trends

From FY2009 onward, Kazia Therapeutics has reported EBITDA for 16 fiscal years.

  • The FY2024 figure marks the lowest annual EBITDA in data going back to FY2009.
  • Per Business Quant data, EBITDA in earlier fiscal years was -$11.92 million in FY2023, -$15.04 million in FY2022, -$9.21 million in FY2021 and -$8.07 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 8.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 8.16 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 5.99 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 4.20 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 7.05 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 30, 2013 -18.42 Mn
Dec 31, 2012 -15.18 Mn
Dec 31, 2009 -323,586.95
API Access

Kazia Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=KZIA&period=max&api_key=YOUR_API_KEY